CN102648908B - 3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 - Google Patents
3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 Download PDFInfo
- Publication number
- CN102648908B CN102648908B CN201110046673.7A CN201110046673A CN102648908B CN 102648908 B CN102648908 B CN 102648908B CN 201110046673 A CN201110046673 A CN 201110046673A CN 102648908 B CN102648908 B CN 102648908B
- Authority
- CN
- China
- Prior art keywords
- edaravone
- borneolum syntheticum
- injection
- application
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QELUYTUMUWHWMC-UHFFFAOYSA-N CC(CC1=O)=NN1c1ccccc1 Chemical compound CC(CC1=O)=NN1c1ccccc1 QELUYTUMUWHWMC-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110046673.7A CN102648908B (zh) | 2011-02-26 | 2011-02-26 | 3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110046673.7A CN102648908B (zh) | 2011-02-26 | 2011-02-26 | 3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102648908A CN102648908A (zh) | 2012-08-29 |
CN102648908B true CN102648908B (zh) | 2015-05-20 |
Family
ID=46691143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110046673.7A Active CN102648908B (zh) | 2011-02-26 | 2011-02-26 | 3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102648908B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668006B (zh) * | 2015-11-06 | 2021-02-05 | 先声药业有限公司 | 3-甲基-1-苯基-2-吡唑啉-5-酮和(+)2-莰醇的组合物的应用 |
CN106668004B (zh) * | 2015-11-06 | 2020-09-04 | 南京先声东元制药有限公司 | 依达拉奉和(+)2-莰醇搽剂及其制备方法 |
CN106727287B (zh) * | 2015-11-23 | 2020-01-24 | 江苏先声药业有限公司 | 依达拉奉和天然冰片的高浓度注射液 |
CN108314652A (zh) * | 2017-01-18 | 2018-07-24 | 周意 | 依达拉奉衍生物及其用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524352A (zh) * | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
-
2011
- 2011-02-26 CN CN201110046673.7A patent/CN102648908B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524352A (zh) * | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
Non-Patent Citations (1)
Title |
---|
氧自由基与银屑病;杨文林;《国外医学皮肤病学分册》;19921231;第18卷(第1期);第10-12页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102648908A (zh) | 2012-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10603301B2 (en) | Cannabis-based extracts and topical formulations for use in skin disorders | |
Piallat et al. | Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6‐OHDA injection: behavioural and immunohistochemical studies | |
El‐Hashim et al. | Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐and NF‐κB‐dependent pathways | |
CN102648908B (zh) | 3-甲基-1-苯基-2-吡唑啉-5-酮与龙脑组合物的应用 | |
US10653669B2 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
CN105534978A (zh) | 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物 | |
Chen et al. | Activation of TLR4/STAT3 signaling in VTA contributes to the acquisition and maintenance of morphine-induced conditioned place preference | |
Chen et al. | Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance | |
CA2971197A1 (en) | Cannabis-based extracts and topical formulations for use in skin disorders | |
US9592217B2 (en) | Method for treating skin inflammatory diseases | |
Rivas et al. | Hypocretinergic system in the medial preoptic area promotes maternal behavior in lactating rats | |
Nițescu et al. | Experimental research in topical psoriasis therapy | |
Gong et al. | Qingpeng ointment ameliorates inflammatory responses and dysregulation of itch-related molecules for its antipruritic effects in experimental allergic contact dermatitis | |
RU2585372C1 (ru) | Фармацевтическая композиция для ингибирования аутофагии двигательных нейронов и её применение | |
CN102648907B (zh) | 3-甲基-1-苯基-2-吡唑啉-5-酮的新用途 | |
Ma et al. | Transcriptomic and metabolomic studies on the protective effect of molecular hydrogen against nuclear electromagnetic pulse-induced brain damage | |
JPWO2008111296A1 (ja) | 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬 | |
Ragule et al. | Update on the physiologic effects of ketamine in general anesthesia and spinal blockade: a review of the literature | |
EP3417856A1 (en) | Cannabis-based extracts and topical formulations for use in skin disorders | |
CN100544729C (zh) | 供静脉用异甘草酸镁制剂及其制备方法 | |
Petrova et al. | Histological structure of the thyroid gland in apolipoprotein E deficient female mice after levothyroxine application | |
AU2013204489A1 (en) | Novel AMPK agonist compositions and methods of use | |
CN101422474A (zh) | 供静脉用异甘草酸镁制剂在治疗皮肤病中的应用 | |
CN104161727A (zh) | 一种阿德呋林脂质体及其制备方法 | |
CN104721193A (zh) | 一种药物制剂及在制备治疗银屑病护理辅助用药中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160715 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180524 Address after: 211800 8 Xing Long Road, Pukou Economic Development Zone, Nanjing, Jiangsu. Co-patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Address before: 210042 699 Xuanwu Road, Xuanwu District, Nanjing, Jiangsu -18 Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.99, Huakang Road, Jiangbei new district, Nanjing, Jiangsu Province, 210032 Patentee after: SIMCERE PHARMACEUTICAL Group Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Address before: 211800 Nanjing, Pukou Economic Development Zone, Jiangsu Road, No. 8 Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |